Viewing Study NCT00273000



Ignite Creation Date: 2024-05-05 @ 4:36 PM
Last Modification Date: 2024-10-26 @ 9:22 AM
Study NCT ID: NCT00273000
Status: UNKNOWN
Last Update Posted: 2006-09-11
First Post: 2006-01-06

Brief Title: The Importance of Glucagon-Like Peptide-2 GLP-2in Mesenteric Bloodflow in Humans
Sponsor: Glostrup University Hospital Copenhagen
Organization: Glostrup University Hospital Copenhagen

Study Overview

Official Title: The Importance of Glucagon-Like Peptide-2 GLP-2in Mesenteric Bloodflow in Humans
Status: UNKNOWN
Status Verified Date: 2005-10
Last Known Status: RECRUITING
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: The purpose of this study is to study the effect of GLP-2 on mesenteric bloodflow in healthy adults by the use of ultrasound it is the hypothesis that GLP-2 vil increase the bloodflow
Detailed Description: The investigation will include 10 testpersons

It will be a 2 fase study over 2 days

day 1 The testperson will meet fasting and take in a standard liquid meal after this the bloodflow in a mesenteric artery will be measured by use of ultrasonic technique Bloodsamples will be taken regular in a total wolumne of 200 ml

day 2The testperson will meet fasting there wil be administered intraveneous GLP-2 in 3 increasing doses over 3 x 45 minand one subcutaneous dose During this the bloodflow in a mesenteric artery will be measured by use of ultrasonic technique Bloodsamples will be taken regular in a total wolumne of 200 ml

Study Oversight

Has Oversight DMC: None
Is a FDA Regulated Drug?: None
Is a FDA Regulated Device?: None
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: None